The same group evaluated adenosine receptors in myeloid cells, and findings suggested that the adenosine receptor ADORA2B is increased in macrophages from IPF patients and preclinical models, and ADORA2B antagonism improves fibrosis and PH in mouse models. Here, ADORA2B is linked to idiopathic pulmonary fibrosis.